Procurement Summary
Country: Germany
Summary: Oh-Biologika-2023-23 Insulin Glargine (Potency: 100 U/Ml)
Deadline: 31 Aug 2025
Posting Date: 28 Jul 2023
Other Information
Notice Type: Tender
TOT Ref.No.: 86399053
Document Ref. No.: 457207-2023
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The health insurers involved are pursuing the goal of concluding discount agreements for the active substance insulin glargine (potency: 100 U/ml) with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V. The contract is concluded as part of the Open House Biologicals procedure of the health insurance companies involved:
Individual negotiations about contract content are not conducted, uniform conditions apply. The cash registers involved do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on September 1st, 2023. The contract ends no later than 31.08.2025, regardless of the date of conclusion of the contract.
All further information can be found in the participation and contract documents.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : OH-Biologika-2023-23
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union, with participation by GPA countries
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-07-24
Publish Date : 2023-07-28
Submission Date : 2025-08-31
Documents
Tender Notice